AMBER CLEMENTS-FORE: Open Payments
NPI 1437448008 · CAVE CITY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 33 payments from 11 companies in 2025. Trend: 2023 $395 · 2024 $500 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $186 |
| Novo Nordisk Inc | 8 | $150 |
| Amgen Inc. | 4 | $64 |
| ABBVIE INC. | 2 | $50 |
| Lilly USA, LLC | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| CVRx, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Krystal Biotech Inc | 1 | $17 |
Products named: Rybelsus, FARXIGA, OTEZLA, BREZTRI, AIRSUPRA, UBRELVY, Wegovy, MOUNJARO.
Industry payments across AR — which companies pay providers there.
